Volume 43, Issue 39, 14 October 2022

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: an emerging therapeutic target

• Extract
• View article

European Heart Journal paper on COVID-19 scoops top award for London-based researcher

• Extract
• View article

EHJ editorial board: changes in clinical trials team

• Extract
• View article

Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?

• Extract
• View article

Control of residual dyslipidaemic risk

• Extract
• View article

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)

• Extract
• View article
• Supplementary data

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

• Abstracts
• View article
• Supplementary data

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

• Abstracts
• View article
• Supplementary data

Pharmacogenetics-guided CETP inhibition: an open question?

• Abstract
• View article

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification

• Abstracts
• View article
• Supplementary data

Lipoprotein(a) and aortic valve stenosis: work in progress

• Abstract
• View article

Heart–brain interactions in cardiac and brain diseases: why sex matters

• Abstracts
• View article

Atypical left anterior descending coronary artery damage after pacemaker lead insertion

• Extract
• View article
• Supplementary data

Optical coherence tomography imaging evidence of thrombus inside the tunnel of Patent Foramen Ovale

• Extract
• View article